Operational aspects of deep learning solutions for Alzheimer's disease

Samuel L. Warren, Ahmed A. Moustafa, Dustin van der Haar

Research output: Chapter in Book / Conference PaperChapter

Abstract

![CDATA[Alzheimer's disease (AD) is the most common form of dementia, characterized by severe cognitive decline and neurodegeneration (Dubois et al., 2007). While there has been extensive research on the diagnosis and treatment of AD in recent decades, the capacity of these combative measures is still severely limited. For example, modern AD diagnoses are prone to misdiagnosing different forms of dementia (e.g., diagnosing vascular dementia as AD) and are unable to detect the early (and potentially reversible) stages of the disease (Arevalo-Rodriguez et al., 2015; James et al., 2020). In turn, there is currently no cure for AD and the disease remains one of the leading causes of death worldwide (WHO, 2019). Consequentially, there is a critical need for diagnostic methods that can diagnose AD at an early and curable stage.]]
Original languageEnglish
Title of host publicationAlzheimer’s Disease: Understanding Biomarkers, Big Data, and Therapy
EditorsAhmed A. Moustafa
Place of PublicationU.K.
PublisherAcademic Press
Pages151-173
Number of pages23
ISBN (Print)9780128213346
Publication statusPublished - 2022

Fingerprint

Dive into the research topics of 'Operational aspects of deep learning solutions for Alzheimer's disease'. Together they form a unique fingerprint.

Cite this